NASDAQ:CYCN | Income Statement | Cyclerion Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$1.77M-$1.77M$16,000.00-$1.76M-$0.41-$0.414,251,0004,251,000
2026-03-31$0.00$730,000.00$3.21M-$3.21M$32,000.00-$3.18M-$0.76-$0.764,205,0004,205,000
2025-12-31$1.03M$519,000.00$1.86M-$838,000.00$39,000.00-$799,000.00-$0.19-$0.19210,000210,000
2025-09-30$875,000.00$348,000.00$1.88M-$1.01M$30,000.00-$976,000.00-$0.30-$0.303,225,0003,225,000
2025-06-30$93,000.00$56,000.00$1.77M-$1.67M$1.35M-$324,000.00-$0.11-$0.113,071,0003,071,000
2025-03-31$81,000.00$36,000.00$1.54M-$1.46M$28,000.00-$1.43M-$0.56-$0.562,556,0002,556,000
2024-12-31$1.81M$56,000.00$1.3M$502,000.00$28,000.00$530,000.00$0.22$0.228,0008,000
2024-09-30$194,000.00$81,000.00$1.32M-$1.13M$405,000.00-$723,000.00-$0.29-$0.292,526,0002,526,000
2024-06-30$0.00$105,000.00$1.38M-$1.38M$62,000.00-$1.32M-$0.53-$0.532,510,0002,510,000
2024-03-31$0.00$44,000.00$1.62M-$1.62M$76,000.00-$1.54M-$0.62-$0.622,494,0002,494,000
2023-12-31$0.00$24,000.00$1.8M-$1.8M$101,000.00-$1.69M-$0.70-$0.7039,00039,000
2023-09-30$0.00$580,000.00$6.02M-$6.02M$107,000.00$7.57M$3.10$2.722,435,0002,786,000
2023-06-30$0.00$339,000.00$1.87M-$1.87M$62,000.00-$4.18M-$1.83-$1.832,282,0002,282,000
2023-03-31$0.00$572,000.00$3.28M-$3.28M$88,000.00-$6.95M-$3.20-$3.202,176,0002,176,000
2022-12-31$0.00$1.18M$4.46M-$4.46M$132,000.00-$7.22M-$3.32-$3.3200
2022-09-30$0.00$1.41M$4.52M-$4.52M$111,000.00-$10.5M-$4.83-$4.832,174,0002,174,000
2022-06-30$306,000.00$10.22M$13.74M-$13.43M$45,000.00-$13.39M-$6.16-$6.162,173,0002,173,000
2022-03-31$711,000.00$9.74M$13.7M-$12.98M$6,000.00-$12.98M-$0.30-$0.3043,42543,425
2021-12-31$533,000.00$10.46M$14.87M-$14.34M-$1,000.00-$10.78M-$0.24-$0.241,414,0001,414,000
2021-09-30$348,000.00$7.03M$11.63M-$11.29M-$5,000.00-$11.29M-$0.26-$0.2643,291,00043,291,000
2021-06-30$3M$12.05M$19.18M-$16.18M-$6,000.00-$16.18M-$0.45-$0.4535,707,00035,707,000
2021-03-31$62,000.00$8.09M$13.46M-$13.4M-$4,000.00-$6.95M34,081,000
2020-12-31$133,000.00$12.09M$19.36M-$19.22M-$4,000.00-$19.23M1,207,000
2020-09-30$400,000.00$13.7M$22.18M-$21.78M$93,000.00-$18.81M32,096,000
2020-06-30$749,000.00$13.79M$20.42M-$19.67M$138,000.00-$19.53M27,791,000
2020-03-31$1.01M$16.83M$21.6M-$20.59M$361,000.00-$20.23M27,669,000
2019-12-31$1.48M$20.68M$28.07M-$26.59M$0.00-$26.06M0
2019-09-30$1.4M$22.3M$29.41M-$28.02M$0.00-$27.32M27,434,000
2019-06-30$1.63M$25.76M$34.68M-$33.05M$0.00-$32.25M27,393,000
2019-03-31$26.4M$37.38M-$37.38M-$37.38M27,380
2018-12-31$22.45M$30.9M-$30.9M$0.00-$30.9M0
2018-09-30$21.5M$29.29M-$29.29M$0.00-$29.29M27,380
2018-06-30$22.25M$29.78M-$29.78M$0.00-$29.78M27,380
2018-03-31$21.51M$25.28M-$25.28M-$25.28M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$2.07M$959,000.00$7.05M-$4.97M$1.45M-$3.53M$0.00-$3.53M-$1.11-$1.113,181,0003,181,000
2024-12-31$2M$286,000.00$5.63M-$3.63M$571,000.00-$3.06M$0.00-$3.06M-$1.21-$1.212,518,0002,518,000
2023-12-31$0.00$1.52M$12.95M-$12.95M$358,000.00-$5.26M$0.00-$5.26M-$2.25-$2.252,338,0002,338,000
2022-12-31$297,000.00$5.98M$18.84M-$18.54M$294,000.00-$44.08M$0.00-$44.08M-$20.28-$20.282,173,0002,173,000
2021-12-31$3.94M$37.64M$59.14M-$55.2M-$16,000.00-$51.65M$0.00-$51.65M-$1.32-$1.3239,144,00039,144,000
2020-12-31$2.3M$56.41M$83.56M-$81.27M$588,000.00-$122.41M$0.00-$77.8M30,403,000
2019-12-31$4.51M$95.14M$129.54M-$125.04M-$122.41M$0.00-$123.01M27,380,000
2018-12-31$87.72M$115.25M-$115.25M-$115.25M$0.00-$115.25M27,380